141 related articles for article (PubMed ID: 38638270)
1. Determinants of tuberculosis among adult people living with HIV on antiretroviral therapy at public hospitals in Hawassa City, South Ethiopia.
Asefa A; Bolka H; Woldesemayat EM
Front Epidemiol; 2024; 4():1353760. PubMed ID: 38638270
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis preventive treatment uptake among people living with HIV during COVID-19 period in Addis Ababa, Ethiopia: a retrospective data review.
Gebreegziabher SB; Ashuro AA; Kumssa TH; Teferi MY; Alemayue EA; Datiko DG; Yimer SA; Shagre MB
BMC Infect Dis; 2024 May; 24(1):499. PubMed ID: 38760665
[TBL] [Abstract][Full Text] [Related]
3. Determinant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa, Ethiopia: a case control study.
Kibret KT; Yalew AW; Belaineh BG; Asres MM
PLoS One; 2013; 8(5):e64488. PubMed ID: 23762214
[TBL] [Abstract][Full Text] [Related]
4. Intensified tuberculosis case finding, implementation of isoniazid preventive therapy and associated factors among people living with human immunodeficiency virus at public health facilities of Harari Region, Eastern Ethiopia: A cross-sectional study.
Geleto A; Abate D; Egata G
Int J Health Sci (Qassim); 2017; 11(1):1-8. PubMed ID: 28293159
[TBL] [Abstract][Full Text] [Related]
5. Predictors of tuberculosis infection among adults visiting anti-retroviral treatment center at east and west Gojjam, northwest, Ethiopia, 2017.
Belew H; Wubie M; Tizazu G; Bitew A; Birlew T
BMC Infect Dis; 2020 Aug; 20(1):593. PubMed ID: 32787798
[TBL] [Abstract][Full Text] [Related]
6. Determinant factors for the occurrence of tuberculosis after initiation of antiretroviral treatment among adult patients living with HIV at Dessie Referral Hospital, South Wollo, Northeast Ethiopia, 2020. A case-control study.
Abdu M; Ali Y; Anteneh S; Yesuf M; Birhanu A; Mohamed S; Hussien A
PLoS One; 2021; 16(3):e0248490. PubMed ID: 33724992
[TBL] [Abstract][Full Text] [Related]
7. Burden of Anemia among Human Immunodeficiency Virus-Positive Adults on Highly Active Antiretroviral Therapy at Hawassa University Compressive Specialized Hospital, Hawassa, Ethiopia.
Tesfaye S; Hirigo M; Jember D; Shifeta M; Ketema W
Anemia; 2023; 2023():2170447. PubMed ID: 37868338
[TBL] [Abstract][Full Text] [Related]
8. Determinants of first-line antiretroviral treatment failure among adult patients on treatment in Mettu Karl Specialized Hospital, South West Ethiopia; a case control study.
Zenu S; Tesema T; Reshad M; Abebe E
PLoS One; 2021; 16(10):e0258930. PubMed ID: 34679085
[TBL] [Abstract][Full Text] [Related]
9. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
[TBL] [Abstract][Full Text] [Related]
10. Isoniazid Preventive Therapy Uptake and Its Effect on Tuberculosis Incidence Among People Living with HIV in Illubabor and Buno Bedelle Zones, South-West Ethiopia, 2022: A Retrospective Cohort Study.
Mulatu G; Gembe M; Chalchisa J; Teklu T; Yismaw W; Dereje D; Wondmagegn H
HIV AIDS (Auckl); 2023; 15():649-662. PubMed ID: 37954622
[TBL] [Abstract][Full Text] [Related]
11. Determinants of Loss to Follow Up Among Adult People Living with HIV Enrolled in Antiretroviral Therapy in West Wollega Public Hospitals, Oromia, Ethiopia.
Benti Biratu S; Addis Gesese A
HIV AIDS (Auckl); 2024; 16():59-71. PubMed ID: 38435497
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.
Yirdaw KD; Jerene D; Gashu Z; Edginton ME; Kumar AM; Letamo Y; Feleke B; Teklu AM; Zewdu S; Weiss B; Ruff A
PLoS One; 2014; 9(8):e104557. PubMed ID: 25105417
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Factors Associated with Delayed Initiation of Antiretroviral Therapy Among People Living with HIV in Nekemte Referral Hospital, Western Ethiopia.
Bayisa L; Tadesse A; Reta MM; Gebeye E
HIV AIDS (Auckl); 2020; 12():457-465. PubMed ID: 33061657
[TBL] [Abstract][Full Text] [Related]
14. Magnitude of Opportunistic Infections and Associated Factors Among HIV-Positive Adults on ART at Selected Public Hospitals in Sidama National Regional State, Southern Ethiopia.
Wachamo D; Bonja F
HIV AIDS (Auckl); 2020; 12():479-487. PubMed ID: 33061659
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis and isoniazid prophylaxis among adult HIV positive patients on ART in Northwest Ethiopia.
Geremew D; Geremew H; Tamir M; Adem M; Tegene B; Bayleyegn B
PLoS One; 2022; 17(4):e0266803. PubMed ID: 35452463
[TBL] [Abstract][Full Text] [Related]
16. Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. A cross-sectional analytical study.
Robert M; Todd J; Ngowi BJ; Msuya SE; Ramadhani A; Sambu V; Jerry I; Mujuni MR; Mahande MJ; Ngocho JS; Maokola W
BMC Infect Dis; 2020 Apr; 20(1):276. PubMed ID: 32276618
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and predictors of tuberculosis infection among people living with HIV in a high tuberculosis burden context.
Njagi LN; Nduba V; Mureithi MW; Mecha JO
BMJ Open Respir Res; 2023 May; 10(1):. PubMed ID: 37197794
[TBL] [Abstract][Full Text] [Related]
18. Time to tuberculosis development and its predictors among HIV-positive patients: A retrospective cohort study.
Ajema AT; Simachew Y; Meshesha MD; Gari T
PLoS One; 2024; 19(2):e0298021. PubMed ID: 38346004
[TBL] [Abstract][Full Text] [Related]
19. Incidence and predictors of tuberculosis occurrence among adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: retrospective follow-up study.
Aemro A; Jember A; Anlay DZ
BMC Infect Dis; 2020 Mar; 20(1):245. PubMed ID: 32216747
[TBL] [Abstract][Full Text] [Related]
20. Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda-patient and health worker perspectives.
Semitala FC; Musinguzi A; Ssemata J; Welishe F; Nabunje J; Kadota JL; Berger CA; Katamba A; Kiwanuka N; Kamya MR; Dowdy D; Cattamanchi A; Katahoire AR
Implement Sci Commun; 2021 Jun; 2(1):71. PubMed ID: 34193311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
